Back

Albuminuria and acute heart failure. Prognostic implications and short-term mortality.

29 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure: new insights and treatments Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Mario Galvan Ruiz

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)

6 More presentations in this session

Presentation thumbnail
The experience of more than three hundred levosimendan administrations: what we have learned
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Two-year outcomes in acute heart failure patients stratified by left ventricular ejection fraction
Doctor A. Feuerstein (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
The hemodynamic and cardiometabolic effects of butyrate infusion in ischemic cardiogenic shock
Mr L. Christensen (Aarhus N, DK)
Abstract Slides Video
Presentation thumbnail
Assessment of biomarkers for iron deficiency following acute decompensated heart failure and its outcomes: a retrospective real-world clinical cohort study
Doctor J. Johansson (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Temporary right heart catheterization in a stable state improves prognosis by optimizing guideline-directed medical therapy in patients with acute heart failure
Doctor R. Matsukawa (Iizuka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure: new insights and treatments

The Event

Event poster

ESC Congress 2025

29 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
The role of albuminuria in acute heart failure: from admission to early post-discharge outcomes
thumbnail
Congress Presentation
Impact and course of albuminuria in acute heart failure according to left or right sided heart failure phenotype
thumbnail
Congress Presentation
Impact of albuminuria in hospitalized patients with acute heart failure. Trajectory and relationship with other cardiac biomarkers.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources